The price of Metlife Inc (NYSE:MET) shares last traded on Wall Street rose 1.68% to $80.11.
MET stock price is now -3.99% away from the 50-day moving average and 5.46% away from the 200-day moving average. The market capitalization of the company currently stands at $55.47B.
With the price target of $97, TD Cowen recently initiated with Buy rating for Metlife Inc (NYSE: MET). On September 05, 2024, Barclays recently initiated its ‘Overweight’ rating on the stock quoting a target price of $91, while ‘Goldman’ rates the stock as ‘Buy’
In other news, DEBEL MARLENE, EVP & Chief Risk Officer sold 22,810 shares of the company’s stock on Dec 13 ’24. The stock was sold for $1,890,577 at an average price of $82.88. Upon completion of the transaction, the EVP & Chief Risk Officer now directly owns 108,507 shares in the company, valued at $8.69 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 13 ’24, President & CEO Khalaf Michel sold 20,926 shares of the business’s stock. A total of $1,733,604 was realized by selling the stock at an average price of $82.84. This leaves the insider owning 500,799 shares of the company worth $40.12 million. A total of 16.44% of the company’s stock is owned by insiders.
During the past 12 months, Metlife Inc has had a low of $64.61 and a high of $89.05. According to the stock market information, the enterprise value for the company is $128620601344, which is based on a 16.16 price-to-earnings ratio, a 1.23 price-to-earnings-growth ratio, and a beta of 1.07. The fifty day moving average price for MET is $83.442 and a two-hundred day moving average price translates $75.95935 for the stock.
The latest earnings results from Metlife Inc (NYSE: MET) was released for 2024-09-30. The net profit margin was 4.99% and return on equity was 13.31% for MET. The company reported revenue of $18.44 billion for the quarter, compared to $15.87 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 16.22 percent.
